Session I: Robust Process and Product Design: Accommodating Uncertainty
Session Co-Chairs: 
Jean Tom, Bristol-Myers Squibb
Dan Pintar, UOP LLC

Speakers: 
Shankar Vaidyaraman, Eli Lilly and Company: 
Investigation of the Impact of Mode of Operation (Batch vs Flow) on Design Space Map
Michael Schaller, The Dow Chemical Co.:
Risk Management for New Process Technology Implementation – Some Key Components
Steven Weisser, GlaxoSmithKline: 
Biopharmaceutical Purification Process Development: Identifying Risks and Dealing with Uncertainty

Session II: Inherently Safer Processes
Session Chair: 
Kathy Kas, The Dow Chemical Co.

Speakers:
Dennis Hendershot, Center for Chemical Process Safety: 
Introduction to Inherently Safer Design
John Dillon, Pfizer: 
The Design of Safe, Efficient and Green Processes for API’s Throughout Product Lifecycle

Session III: Scale-Up Issues: Examples and Effective Solutions
Session Co-Chairs: 
Robert Lin, Eastman Chemical Co.
Shaibal Roy, DuPont

Speakers:
David Berg, DuPont: 
Use of Piloting to Reduce Scale-Up Risk
Martin Johnson, Eli Lilly and Company: 
Design and Scale Up of Fully Continuous Processes including Reaction, Workup, and Isolation
Brad Duckworth, Eastman:
The Search for the Piloting and Scale-Up Vision of the Future

Session V: Innovation: Feeding the Funnel
Session Co-Chairs:  
Bob Huss, Eastman Chemical
Kevin Joback, Molecular Knowledge Systems

Speakers:
Kevin Joback, Molecular Knowledge Systems: 
Using Physical Properties to Develop Better Chemical Products and Processes
Monty Alger & Scott Siegmund, Air Products: 
Developing and Adapting Novel Ideas for Plant Upgrades
Michael Schultz, Lanzatech: 
Develop the Right Innovative Concepts Using Early Stage Process Design

Session VI: Multi-Functional Teams: Collecting Experiences to Maximize Insights
Session Co-Chairs: 
Lionel O'Young, ClearWaterBay Technology
Joe Cramer, AIChE

Speakers:
Jack Hipple, Innovation TRIZ: 
Working with Parallel Universes
Mark Shmorhun, Myriant Corporation: 
From Process Technology to Commercial Scale Production
Michael Popule, Air Products: 
Global Dimensions of New Product Development: A Case Study

Session VII:  Planning Project Handoffs
Session Co-Chairs: 
John Peragine, Bristol-Myers Squibb
Cheryl Teich, The Dow Chemical Co.

Speakers:
John Peragine,  Bristol-Myers Squibb: 
Transfer of Pharmaceutical Finished Product Processes to Third Party Manufacturers
Joan Roller, CRI
Outsourcing of Manufacturing Services from the Tolling Company’s Perspective
Ron Leng, The Dow Chemical Co.: 
Technology Transfer - Managing the Handoff